Killing cancer by protecting normal cells

14 noviembre 2014

An anti-cancer drug protects normal cells from radiation damage and increases the effectiveness of radiation therapy in prostate cancer models, investigators report. Using human prostate cancer cells growing in mice, the researchers also showed that RTA 408 did not confer radiation protection to the cancer cells. In fact, when RTA 408 was given alone, without radiation, it also slowed the growth of human prostate cancer transplants in mice. In combination, it further amplified the tumor growth inhibitory effects of radiation.